Health News

Activity Of Rare Genetic Variant In Glioma Validated

Date: Jul-05-2012
Researchers at Moffitt Cancer Center working with colleagues at three other institutions have validated a link between a rare genetic variant and the risk of glioma, the most common and lethal type of brain tumor. The validation study also uncovered an association between the same rare genetic variant and improved rates of survival for patients with glioma. The study, the first to confirm a rare susceptibility variant in glioma, appeared in a recent issue of the Journal of Medical Genetics, a journal published by the British Medical Association...

Reflection Is Critical For Development And Well-Being

Date: Jul-05-2012
As each day passes, the pace of life seems to accelerate - demands on productivity continue ever upward and there is hardly ever a moment when we aren't, in some way, in touch with our family, friends, or coworkers. While moments for reflection may be hard to come by, a new article suggests that the long-lost art of introspection - even daydreaming - may be an increasingly valuable part of life...

Sports Medicine Implants Market Sprints Ahead As Injuries Become More Common

Date: Jul-05-2012
The growing number of people injuring themselves during sport is driving the sports medicine implants market, states a new report by healthcare experts GlobalData. According to the research*, an increase in injury rates in combination with an aging population and more technologically advanced implant options will see the global sports medicine implant market grow from a 2011 figure of $1 billion, to reach $1.6 billion by 2018, at a Compound Annual Growth Rate (CAGR) of 6.7%. The US has the largest market for these implants, accounting for 49% of the global market last year...

MRSA Infections Have Declined

Date: Jul-04-2012
Department of Defense have announced an analysis of more than nine million active and non active military personnel, showing a decline in rates of MRSA infections in both hospitalized patients and those in the community, a new report published in JAMA (Journal of the American Medical Association) informed. MRSA (Methicillin-resistant Staphylococcus aureus) has become an increasing issue in recent years, with more infections of the staph bacteria that's become resistant to the antibiotics that commonly used to treat ordinary staph infections...

Legionnaires' Outbreak In Scotland Claims Third Life

Date: Jul-04-2012
A third man being treated for Legionnaires' disease in the outbreak in Scotland has died, health authorities said on Tuesday. The outbreak, which started at the end of May, is believed so far to have sickened 99 people, 49 with confirmed infection by Legionella bacteria and another 50 suspected cases. Although the source of the outbreak in Scotland is thought to be somewhere in the south of Edinburgh, the authorities are still unable to locate it. Most of the confirmed cases are linked to the Dalry, Gorgie and Saughton areas of the city, reported The Scotsman on Tuesday...

Noonan Syndrome Diagnosis Sped Up By New Genetic Test

Date: Jul-04-2012
A new gene test will greatly improve the speed and clarity of diagnosis for a complex range of genetic disorders, known as rasopathies, including Noonan Syndrome. The new test has been developed by molecular diagnostic testing company NewGene in collaboration with the South West Thames Regional Genetics Service at St George's Healthcare NHS Trust in London, the specialist centre for Noonan Syndrome and associated hereditary disorders in the UK...

Clinical Discovery Annual Conference 2012, 16th October, London

Date: Jul-04-2012
Events 4 Healthcare Ltd, who specialise in delivering bespoke events for the Healthcare and Pharmaceutical industry, today announced details of its Clinical Discovery Annual Conference 2012, to be held on Tuesday 16th October, 2012 at The Royal Society, London. New models for the value-based pricing of pharmaceuticals are actively in development. Decision-makers in healthcare are increasingly using the highest quality scientific evidence to support clinical and health policy choices...

Biomarkers In Drug Discovery & Development 2012, 10-11 September, Berlin, Germany

Date: Jul-04-2012
At this specific event participants will meet eminent representatives from big pharma companies such as Pfizer, Sanofi, Bayer, Janssen, Novartis as well as highly qualified experts from academia and research institutes. They are enthusiastic about sharing their knowledge, experience and practices and provide further advices and fresh ideas to their business peers...

Some "Technically At Term" Infants Have Lower Third Grade Scores Later On

Date: Jul-04-2012
Previous research had found that infants born at 34 to 36 weeks' gestation - classified as "late preterm" - have an increased risk of developmental delays and other mental and medical difficulties. A new study suggests even infants born at 37 or 38 weeks' gestation - technically "at term" - are at risk. The study, "Academic Achievement Varies With Gestational Age Among Children Born at Term," in the August 2012 Pediatrics (published online July 2), analyzed data from 128,000 babies born between 37 and 41 weeks' gestation in New York City...

Caffeine Intake Tied To Lower Risk Of Common Skin Cancer

Date: Jul-04-2012
A new US study of over 110,000 people found that the more caffeine there was in their diets, the lower their risk of developing basal cell carcinoma, the most common type of skin cancer. The researchers write about their findings in the 1 July issue of the journal Cancer Research. However, lead investigator Dr Jiali Han, associate professor at Brigham and Women's Hospital, Harvard Medical School in Boston and Harvard School of Public Health, told the press: "I would not recommend increasing your coffee intake based on these data alone...